Episode 34: Advancing Vaccine Development: A Conversation with Professor Nikolai Petrovsky episode artwork

EPISODE · Jan 25, 2025 · 35 MIN

Episode 34: Advancing Vaccine Development: A Conversation with Professor Nikolai Petrovsky

from Immunity Group Podcast · host Immunity Group Australia

In this episode, we sit down with Professor Nikolai Petrovsky, a leading figure in vaccine development, to explore the groundbreaking work his team is doing in the fight against infectious diseases, Alzheimer’s, and cancer. Professor Petrovsky provides updates on the progress of the H5 influenza vaccine, the clinical trial for an Alzheimer’s vaccine in Adelaide, and the continued development of cancer vaccines. He also shares the challenges and opportunities presented by mRNA technology, alongside his personal journey from medicine to the forefront of vaccine innovation. Despite facing bureaucratic challenges, Professor Petrovsky is setting up operations in the United States to further advance his team’s mission. Join us for an insightful discussion on the future of vaccine development and the importance of continued scientific research in addressing global health challenges.

Episode metadata supplied by the publisher feed · Published Jan 25, 2025

Embed this episode

NOW PLAYING

Episode 34: Advancing Vaccine Development: A Conversation with Professor Nikolai Petrovsky

0:00 35:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Immunity Group Podcast?

This episode is 35 minutes long.

When was this Immunity Group Podcast episode published?

This episode was published on January 25, 2025.

Can I download this Immunity Group Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!